Pillstats
Rx only · Suspension · Oral

Rufinamide

Brands: Banzel · Rufinamide

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)69036
US makers10 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.196$0.392$0.588$0.784Dec 2025Apr 2026Jul 2026
$0.585
Latest avg · Jul 22, 2026
-14%
Since Dec 17, 2025
10
Active US suppliers
20%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.3K8.6K13K17K2025 Q12025 Q22025 Q32025 Q42026 Q1
14K
Rx · 2026 Q1
13.7M
Units dispensed
-2%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it10 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novadoz Pharmaceuticals LLCunknown1SUPPLYING
NorthStar RxLLCunknown1SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Eisai Inc.unknown1SUPPLYING
Ascend Laboratories, LLCunknown1SUPPLYING
Bionpharma Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.